Spravato vs IV Ketamine Near Seattle & Bellevue: Which Is Right for You?

Your psychiatrist mentioned two options for your treatment-resistant depression: Spravato or IV ketamine infusions. Both sound similar, both involve ketamine, but one costs $1,200 per session while the other is $400. One is FDA-approved and covered by insurance. The other is “off-label” but has decades of research. The confusion is real. This guide breaks down exactly what separates these treatments so you can make an informed decision.

The question isn’t new. Every week, patients ask me this in consultations: “Should I try Spravato or IV ketamine?” The answer isn’t as simple as “one is better.” It depends on your insurance, your timeline, and what you value most in treatment.

Let me break down what actually matters.

What Are Spravato and IV Ketamine?

Both treatments use ketamine, a medication that’s been used safely in medical settings for over 50 years. The difference lies in the chemical form, the delivery method, and the regulatory approval.

Spravato (Esketamine)

Spravato is the brand name for esketamine, which is the S-enantiomer of ketamine. Think of it as one half of the ketamine molecule. Johnson & Johnson developed it specifically for depression, received FDA approval in 2019, and it’s delivered as a nasal spray.

The S-enantiomer has 2-3 times higher affinity for NMDA receptors than the full ketamine molecule, which theoretically allows for lower dosing. This is the marketing pitch. The clinical reality is more nuanced.

IV Ketamine

IV ketamine is racemic ketamine, meaning it contains equal parts of both the S-enantiomer (esketamine) and the R-enantiomer (arketamine). It’s delivered directly into the bloodstream through an IV infusion over 40-60 minutes.

Ketamine has been FDA-approved as an anesthetic since 1970. Using it for depression is “off-label,” meaning doctors prescribe it for a purpose not officially approved by the FDA. This is common in medicine and completely legal.

The 5 Key Differences That Actually Matter

Forget the marketing. Here’s what separates these treatments in ways that affect your actual experience.

Factor	Spravato (Esketamine)	IV Ketamine
FDA Approval	Yes – approved 2019 for TRD	No – used off-label
Insurance Coverage	Usually covered (with prior auth)	Rarely covered
Delivery Method	Nasal spray (self-administered)	IV infusion (medical staff)
Bioavailability	~48% (nasal absorption varies)	100% (direct to bloodstream)
Monitoring Required	2 hours (REMS program)	45-90 minutes typical
Cost Per Session (no insurance)	$590-$885	$400-$800
Time to Start	Days to weeks (prior auth)	Usually immediate

Why FDA Approval Matters (and When It Doesn’t)

FDA approval isn’t just a stamp. It determines insurance coverage, standardizes safety protocols, and creates clear treatment guidelines. Spravato’s approval means most major insurers cover it after you’ve tried 2-3 antidepressants.

IV ketamine’s off-label status doesn’t make it experimental or unsafe. Many effective treatments in psychiatry are used off-label. The issue is financial: insurance won’t cover it, so you pay the full cost.

Insurance Coverage: The Spravato Advantage

This is often the deciding factor. If your insurance covers Spravato, the out-of-pocket cost difference is massive.

How Spravato Insurance Coverage Works

Most major insurance plans cover Spravato, including Medicare Part B, Medicaid, Blue Cross Blue Shield, Aetna, Cigna, United Healthcare, and Tricare. But coverage requires meeting specific criteria:

Insurance Provider	Required Failed Trials	Patient Cost With Insurance
Medicare Part B	2+ antidepressants	20% coinsurance ($140-$240/session)
Aetna	2+ (different classes)	$10-$50 copay typical
Blue Cross Blue Shield	2+ antidepressants	$10-$200 copay
Cigna	2+ (different classes)	$20-$100 copay
United Healthcare	3+ antidepressants	$20-$150 copay

The “Buy and Bill” model means your doctor purchases the medication and bills insurance for both the drug and monitoring. With Medicare plus supplemental insurance, many patients pay $0 per session. With commercial insurance, copays range from $10-$200 depending on your plan.

IV Ketamine Insurance Reality

Most insurance plans do not cover IV ketamine for depression because it’s used off-label. You pay the full session cost: typically $400-$800 per infusion.

Some exceptions exist. If you have a Health Savings Account (HSA) or Flexible Spending Account (FSA), you can use those funds. A few insurance companies will reimburse out-of-network claims, but don’t count on it. The ASKP3 organization is working to change this, advocating for coverage and fair reimbursement rates.

Effectiveness: What the Research Shows

The clinical question: does one work better than the other?

Harvard’s 2025 Head-to-Head Study

The largest comparison study to date examined 153 patients with treatment-resistant depression. Half received IV ketamine, half received intranasal esketamine. The results showed IV ketamine produced slightly faster symptom relief after the first treatment (49% depression score reduction vs 40% for esketamine), but both were highly effective.

By the end of the study period, response rates and remission rates were essentially identical. Both treatments worked. The difference was speed, not ultimate effectiveness.

Real-World Clinical Data

Outcome Measure	Spravato (Esketamine)	IV Ketamine
Response Rate (≥50% improvement)	63-70%	55-76%
Remission Rate (minimal symptoms)	29-52%	27-43%
Time to Initial Effect	4-24 hours	40 minutes – 24 hours
Duration of Effect	7-14 days per dose	7-14 days per infusion
Discontinuation Due to Side Effects	Similar between groups	Similar between groups

A 2024 multicenter study found similar effectiveness and safety between IV ketamine and Spravato in real-world settings. Both reduced depressive symptoms significantly, with no major differences in side effect profiles or treatment discontinuation rates.

How Each Treatment Is Administered

The experience of receiving these treatments differs substantially. Understanding what to expect helps reduce anxiety.

Spravato Administration Protocol

Spravato follows strict REMS (Risk Evaluation and Mitigation Strategy) program guidelines. Here’s the typical session:

Before Treatment: You check in 30 minutes early. The clinical team verifies you haven’t eaten within 2 hours (food increases nausea risk). They check your blood pressure and confirm you have a ride home arranged.

During Treatment: You self-administer the nasal spray under supervision. The device delivers a precise dose (56mg or 84mg depending on your treatment phase). You’ll spray once in each nostril, wait 5 minutes, then repeat. Total administration time is about 10 minutes.

Post-Treatment Monitoring: This is where Spravato differs from IV ketamine. You must remain at the clinic for 2 hours after dosing. A healthcare professional checks on you every 15-20 minutes, monitors blood pressure, and assesses for adverse reactions. You cannot leave until your provider determines you’re clinically stable, even if you feel fine.

Going Home: Someone must drive you. You cannot operate vehicles or heavy machinery until the next day after a full night’s sleep. This is non-negotiable.

IV Ketamine Administration Protocol

IV ketamine protocols vary more between clinics since there’s no standardized REMS program. A typical session looks like this:

Before Treatment: You arrive 15-30 minutes early. The nurse places an IV line, typically in your arm or hand. Some clinics check vitals; others are less structured.

During Treatment: The ketamine infusion runs for 40-60 minutes at a controlled rate (typically 0.5 mg/kg). You recline in a comfortable chair, often with music, eye mask, or other comfort measures. Many patients describe a dreamlike state or mild dissociation during this period.

Post-Treatment Monitoring: After the infusion finishes, most clinics observe you for 15-45 minutes. Once you’re alert and your vitals are stable, you can leave. Total session time is typically 90-120 minutes, shorter than Spravato’s mandatory 2-hour monitoring.

Going Home: You need someone to drive you home. Some clinics are less strict about this than Spravato providers, but it’s still recommended for safety.

Side Effects and Safety

Both treatments share similar side effect profiles because they’re both ketamine-based. The differences lie in intensity and duration.

Side Effect	Spravato Frequency	IV Ketamine Frequency
Dissociation	40-61%	50-75%
Nausea	27-28%	20-30%
Dizziness	24-27%	25-35%
Headache	20-24%	15-20%
Blood Pressure Increase	8-17%	10-20%
Sedation	22-26%	30-40%

Most side effects resolve within 90 minutes to 2 hours. Serious adverse events are rare with both treatments when properly monitored. The REMS program for Spravato exists specifically to manage cardiovascular risks and monitor for dissociation.

Contraindications for both treatments include aneurysmal vascular disease, arteriovenous malformation, history of intracerebral hemorrhage, uncontrolled hypertension, and severe cardiovascular disease.

Real-World Cost Comparison

Cost is often the deciding factor. Let me show you the actual numbers for a typical treatment course.

Acute Treatment Phase (First 4-6 Weeks)

Treatment Component	Spravato	IV Ketamine
Sessions Required	8 sessions (twice weekly for 4 weeks)	6-8 infusions (2-3x per week)
Cost Per Session (No Insurance)	$590-$885	$400-$800
Total Acute Phase Cost (No Insurance)	$4,720-$7,080	$2,400-$6,400
With Insurance Coverage	$80-$1,600 total (copays only)	$2,400-$6,400 (rarely covered)

Maintenance Phase (Ongoing)

After the acute phase, most patients transition to maintenance dosing to prevent relapse.

Spravato Maintenance: Typically once weekly for weeks 5-8, then every other week or monthly. With insurance, you’re paying your regular copay. Without insurance, you’re paying $590-$885 per session indefinitely.

IV Ketamine Maintenance: Usually once every 2-4 weeks. Some patients find they need less frequent boosters than with Spravato. At $400-$800 per infusion out-of-pocket, this adds up quickly.

Which Treatment Is Right for You?

There’s no universal answer. The right choice depends on your specific situation.

Choose Spravato If:

You have insurance coverage. This is the biggest factor. If your insurance covers Spravato and you meet the criteria (2-3 failed antidepressant trials), your out-of-pocket costs will be dramatically lower than IV ketamine. For many patients, this makes Spravato the only financially viable option.

You want FDA-approved treatment. Some patients feel more comfortable with FDA-approved medications. The approval process provides standardized safety data and treatment protocols.

You prefer nasal administration. Some patients find nasal spray less invasive than IV placement, though you still need the 2-hour monitoring period.

You’re comfortable with the REMS requirements. The strict monitoring adds safety but requires more time commitment (2 hours per session vs 90 minutes).

Choose IV Ketamine If:

You need to start treatment immediately. IV ketamine clinics can often schedule you within days. Spravato requires prior authorization, which takes 1-3 weeks. If you’re in crisis, speed matters more than insurance savings.

You don’t have insurance or your insurance won’t cover Spravato. Without insurance coverage, IV ketamine is often less expensive per session ($400-$800 vs $590-$885).

You want more flexible maintenance schedules. Some clinics report patients need less frequent IV ketamine boosters than Spravato maintenance dosing, though this varies individually.

You prefer IV delivery with consistent bioavailability. IV administration delivers 100% of the dose directly to your bloodstream, while nasal spray absorption varies (around 48%).

Consider Alternatives If:

Both treatments involve dissociation and significant time commitment. If you’re hesitant about ketamine-based treatments, ask your psychiatrist about:

TMS (Transcranial Magnetic Stimulation): No dissociation, no medication, FDA-approved, often covered by insurance. It requires daily sessions for 6 weeks but has 60-70% response rates for treatment-resistant depression.

ECT (Electroconvulsive Therapy): The most effective treatment for severe depression, with 70-90% response rates. Requires anesthesia and can cause temporary memory issues.

Medication optimization: Sometimes adding augmentation strategies like lithium, thyroid hormone, or trying newer antidepressants can help without requiring ketamine treatments.